Bartlett & Co’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,036
Closed -$15K 847
2020
Q2
$15K Hold
2,036
﹤0.01% 638
2020
Q1
$12K Buy
+2,036
New +$14.4K ﹤0.01% 636
2019
Q3
$4K Hold
2,036
﹤0.01% 791
2019
Q2
$10K Hold
2,036
﹤0.01% 587
2019
Q1
$11K Hold
2,036
﹤0.01% 570
2018
Q4
$8K Hold
2,036
﹤0.01% 594
2018
Q3
$15K Hold
2,036
﹤0.01% 571
2018
Q2
$18K Hold
2,036
﹤0.01% 539
2018
Q1
$33K Hold
2,036
﹤0.01% 475
2017
Q4
$36K Hold
2,036
﹤0.01% 466
2017
Q3
$46K Hold
2,036
﹤0.01% 439
2017
Q2
$55K Hold
2,036
﹤0.01% 424
2017
Q1
$46K Hold
2,036
﹤0.01% 439
2016
Q4
$44K Hold
2,036
﹤0.01% 448
2016
Q3
$69K Hold
2,036
﹤0.01% 372
2016
Q2
$65K Hold
2,036
﹤0.01% 381
2016
Q1
$89K Hold
2,036
﹤0.01% 322
2015
Q4
$48K Hold
2,036
﹤0.01% 430
2015
Q3
$48K Hold
2,036
﹤0.01% 422
2015
Q2
$70K Hold
2,036
﹤0.01% 371
2015
Q1
$92K Hold
2,036
﹤0.01% 327
2014
Q4
$111K Hold
2,036
0.01% 312
2014
Q3
$122K Hold
2,036
0.01% 295
2014
Q2
$172K Hold
2,036
0.01% 262
2014
Q1
$130K Buy
+2,036
New +$174K 0.01% 282

Other funds holding NNVC

Bartlett & Co's NNVC Position: Q3 2020 in Review

Bartlett & Co sold out of NanoViricides (NNVC) in Q3 2020, closing a stake of 2,036 shares — an estimated $15K sold.

Bartlett & Co first reported a position in NNVC in Q1 2014 and held it in 25 quarters. The position peaked at $172K in Q2 2014. 36 funds tracked by Wall St. Rank hold NNVC as of Q3 2020.

  • Bartlett & Co reported no remaining NanoViricides position as of Q3 2020 after selling out during the quarter.
  • Bartlett & Co sold 2,036 NanoViricides shares in Q3 2020, an estimated $15K.
  • Bartlett & Co first reported a position in NanoViricides in Q1 2014 and held it in 25 quarters.
  • Bartlett & Co's NanoViricides position peaked at $172K in Q2 2014.
  • 36 funds tracked by Wall St. Rank held NanoViricides as of Q3 2020.

Based on Bartlett & Co's 13F filing for Q3 2020, filed 20 Oct 2020.